The hearing, which commenced on Tuesday, 18 February, 2025, is being overseen by US Bankruptcy Judge Christopher Lopez in ...

Nearly six weeks after Johnson & Johnson paused the U.S. external evaluation of its Varipulse pulsed field ablation catheter ...

Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby ...

The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson Abiomed Impella RP heart ...

Volta Medical put forward new data showing its artificial-intelligence-guided ablation procedures were able to improve ...

A recent pause in U.S. sales of Varipulse is hampering the company’s bid to catch up in one of the industry’s fastest-growing ...

Johnson & Johnson is looking to sell its Cerenovus stroke therapy business, according three unnamed people "with knowledge of ...

Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...

Johnson & Johnson (NYSE:JNJ) has put its stroke care business up for sale, aiming for a valuation of more than $1B, the Financial Times reported on Tuesday, citing people familiar with the matter.

Read about the spot won by J&J Worldwide Services on a U.S. Army multiple-award contract to provide repair, renovation and ...

B Health and two safety-net hospitals want to help the government prove that drugmakers are required to give upfront discounts on 340B drugs.